Market Overview:
The global acne prescription medication market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of acne, rising awareness about available treatment options, and growing demand for better-quality products. The global acne prescription medication market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into topical and oral medications. Topical medications are further sub-segmented into antibiotics, retinoids/retinoid analogs (tazarotene), benzoyl peroxide preparations (BPO), azelaic acid preparations (AAPs), hormonal therapies (including spironolactone and cyproterone acetate [CPA]), salicylic acid preparations (SAs) moisturizers/emollients). Oral medications are further sub-segmented into systemic antibiotics, isotretinoin therapy agents erythromycin therapy agents tetracycline therapy agents minocycline therapy agents doxycycline therapy agent dapsone monotherapy agent .On the basis of application,the market is segmentedinto inflammatoryacneand noninflammatoryacne.
Product Definition:
Acne Prescription Medication is a medication prescribed by a doctor to treat acne. Acne is a skin condition that occurs when the pores become clogged with oil and dead skin cells. This can lead to blackheads, whiteheads, and inflamed red lesions called pimples or zits. Acne prescription medication may be used alone or in combination with other treatments, such as laser therapy or chemical peels.
Topical:
Topical medications are those used to treat acne and related skin conditions that are external or surface-level treatments. These medications can be applied directly to the skin, usually in the form of creams, gels, liquids or foam. They may also be taken by mouth as tablets or capsules. Topical drugs act against the oil glands present on the face and neck; this leads to excessive oily skin production that causes acne breakouts.
Oral:
Oral is a medication that is prescribed to treat acne. It works by reducing the production of sebum, a oily substance that causes acne. Sebum normally flows through pores on the skin and if it'sproduction is not reduced then it can lead to severe acne breakouts. The drug works best when it's taken in conjunction with other medications such as antibiotics or anti-inflammatory drugs because they help reduce inflammation caused by bacteria in the pores which makes Oral work more effectively.
Application Insights:
The inflammatory acne segment dominated the global market in 2017. It is also expected to be the fastest-growing application over the forecast period owing to its high prevalence and treatment seeking behavior. The non-inflammatory acne segment is anticipated to witness significant growth during the forecast period owing to increasing awareness about this disease and growing preference for natural treatments among patients.
Inflammatory Acne: This type of acne results from an excess production of sebum by the skin glands resulting in blocked pores on affected areas of skin. It often occurs during puberty as a result of hormonal changes coupled with environmental factors such as stress, pollution, etc., leading to symptoms such as redness, swelling & pain in pimples that last for 2 or 3 weeks before they heal completely.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing consumer awareness about acne treatment options, high disposable income, and availability of effective treatments for acne. In addition, higher adoption of new technologies and a large number of players operating in this region also contributes to the dominance of this region.
Asia Pacific is expected to witness rapid growth over the forecast period owing to an increase in consumer awareness about available treatment options for acne along with rising disposable income levels which eventually leads towards improved healthcare facilities including better dermatology care & diagnosis. Moreover, growing penetration & accessibility of insurance coverage are further expected boost regional growth during the forecast period (2018-2030). However, stringent regulations regarding drug approval from different regulatory agencies may pose as a challenge for market growth in some countries such as India and China (Southeast Asia).
Growth Factors:
- Increasing incidence of acne across all age groups
- Growing awareness about the available treatment options for acne
- Rising demand for effective and safe acne prescription medications
- Proliferation of online platforms that offer information on various acne treatments
- Availability of affordable and accessible prescription medications for acne
Scope Of The Report
Report Attributes
Report Details
Report Title
Acne Prescription Medication Market Research Report
By Type
Topical, Oral
By Application
Inflammatory Acne, Non-inflammatory Acne
By Companies
Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma, Lion, HUAPONT, Sine Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Acne Prescription Medication Market Report Segments:
The global Acne Prescription Medication market is segmented on the basis of:
Types
Topical, Oral
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Inflammatory Acne, Non-inflammatory Acne
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Galderma
- Bausch Health
- Teva
- GlaxoSmithKline
- Mylan
- Almirall
- Sun Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Sine Pharma
Highlights of The Acne Prescription Medication Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical
- Oral
- By Application:
- Inflammatory Acne
- Non-inflammatory Acne
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acne Prescription Medication Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acne prescription medication is a type of medication prescribed to treat acne. Acne medications can be classified as topical or systemic. Topical acne medications are applied directly to the skin and systemic acne medications are taken by mouth.
Some of the key players operating in the acne prescription medication market are Galderma, Bausch Health, Teva, GlaxoSmithKline, Mylan, Almirall, Sun Pharma, Mayne Pharma, Lion, HUAPONT, Sine Pharma.
The acne prescription medication market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acne Prescription Medication Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acne Prescription Medication Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acne Prescription Medication Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acne Prescription Medication Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acne Prescription Medication Market Size & Forecast, 2018-2028
4.5.1 Acne Prescription Medication Market Size and Y-o-Y Growth
4.5.2 Acne Prescription Medication Market Absolute $ Opportunity
Chapter 5 Global Acne Prescription Medication Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Acne Prescription Medication Market Size Forecast by Type
5.2.1 Topical
5.2.2 Oral
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Acne Prescription Medication Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Acne Prescription Medication Market Size Forecast by Applications
6.2.1 Inflammatory Acne
6.2.2 Non-inflammatory Acne
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acne Prescription Medication Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acne Prescription Medication Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Acne Prescription Medication Analysis and Forecast
9.1 Introduction
9.2 North America Acne Prescription Medication Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Acne Prescription Medication Market Size Forecast by Type
9.6.1 Topical
9.6.2 Oral
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Acne Prescription Medication Market Size Forecast by Applications
9.10.1 Inflammatory Acne
9.10.2 Non-inflammatory Acne
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Acne Prescription Medication Analysis and Forecast
10.1 Introduction
10.2 Europe Acne Prescription Medication Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Acne Prescription Medication Market Size Forecast by Type
10.6.1 Topical
10.6.2 Oral
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Acne Prescription Medication Market Size Forecast by Applications
10.10.1 Inflammatory Acne
10.10.2 Non-inflammatory Acne
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Acne Prescription Medication Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Acne Prescription Medication Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Acne Prescription Medication Market Size Forecast by Type
11.6.1 Topical
11.6.2 Oral
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Acne Prescription Medication Market Size Forecast by Applications
11.10.1 Inflammatory Acne
11.10.2 Non-inflammatory Acne
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Acne Prescription Medication Analysis and Forecast
12.1 Introduction
12.2 Latin America Acne Prescription Medication Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Acne Prescription Medication Market Size Forecast by Type
12.6.1 Topical
12.6.2 Oral
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Acne Prescription Medication Market Size Forecast by Applications
12.10.1 Inflammatory Acne
12.10.2 Non-inflammatory Acne
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Acne Prescription Medication Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Acne Prescription Medication Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Acne Prescription Medication Market Size Forecast by Type
13.6.1 Topical
13.6.2 Oral
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Acne Prescription Medication Market Size Forecast by Applications
13.10.1 Inflammatory Acne
13.10.2 Non-inflammatory Acne
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acne Prescription Medication Market: Competitive Dashboard
14.2 Global Acne Prescription Medication Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Galderma
14.3.2 Bausch Health
14.3.3 Teva
14.3.4 GlaxoSmithKline
14.3.5 Mylan
14.3.6 Almirall
14.3.7 Sun Pharma
14.3.8 Mayne Pharma
14.3.9 Lion
14.3.10 HUAPONT
14.3.11 Sine Pharma
